[HTML][HTML] Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta …

…, D Low-Beer, N Luhmann, G Macphail… - The lancet …, 2023 - thelancet.com
Background Measuring the incidence of HIV and hepatitis C virus (HCV) infection among
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …

Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized …

RJ Hilsden, G Macphail, J Grebely… - Clinical Infectious …, 2013 - academic.oup.com
Background. This study investigated the efficacy and safety of directly observed pegylated
interferon (peg-IFN) alfa-2a plus self-administered ribavirin (RBV) for the treatment of hepatitis …

Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients

…, B Haslam, SS Lee, G Macphail… - … Open Access Journal, 2018 - cmajopen.ca
Background: High hepatitis C cure rates have been observed in registration trials with
second-generation direct-acting antivirals. Real-world data also indicate high sustained viral …

Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs

…, L Tyrrell, CS Coffin, G Macphail - Canadian Liver …, 2020 - canlivj.utpjournals.press
BACKGROUND: Approximately 60% of incident hepatitis C virus (HCV) infections are due
to intravenous drug use; therefore, understanding the socio-demographics of people who …

Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study

…, R Thomas, D Webster, G Macphail… - Canadian Liver …, 2020 - canlivj.utpjournals.press
BACKGROUND: People who use drugs (PWUD) are among the highest risk category for
becoming infected with the hepatitis C virus (HCV) in Canada. There is a need for more …

The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with …

…, EM Yoshida, B Rajendran, G Macphail… - Canadian Liver …, 2020 - canlivj.utpjournals.press
Background: Canada was the first country to approve elbasvir/grazoprevir (EBR/GZR) for
the treatment of chronic HCV infection for genotypes 1 and 4 with or without ribavirin and …

Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs

…, CS Coffin, MD Gisela Macphail - …, 2020 - canlivj.utpjournals.press
BACKGROUND: Approximately 60% of incident hepatitis C virus (HCV) infections are due
to intravenous drug use; therefore, understanding the socio-demographics of people who …

Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study

…, DHC OQ, MD Duncan Webster, MD Gisela Macphail… - canlivj.utpjournals.press
BACKGROUND: People who use drugs (PWUD) are among the highest risk category for
becoming infected with the hepatitis C virus (HCV) in Canada. There is a need for more …

[CITATION][C] RE: Leo died the other day

GLP Macphail - 2024 - Can Med Assoc
I sympathize with the author's heartfelt sadness at Leo's final hours. However, I respectfully
disagree with her conclusion. The emotionally charged story of Leo should lead us to better …

[CITATION][C] OUTCOMES OF HEPATITIS C TREATMENT ARE SIMILAR IN CANADIAN INDIGENOUS PEOPLE COMPARED TO NON-INDIGENOUS PATIENTS

…, AOAA Hamour, L Barrett, G Macphail… - The Liver Meeting …, 2020 - aasld.confex.com